← back to search

Xiubing Zhang

Guangzhou University of Chinese Medicine · CN
Area of research
Electronic, Optical and Magnetic Materials · Public Health, Environmental and Occupational Health
Research interest
Research interests include Cancer research, Hepatocellular carcinoma, Biology, Gene knockdown, Glioma, and Cell cycle.
h-index
citations
330
works
20
NIH funding
primary concept
email

Recent publications

A mouse model of sepsis-associated DIC induced by Kappa-carrageenan and Lipopolysaccharides: Establishment and characteristics
Journal of Advanced Research 2025cited by 2position: middledoi
GRWD1 inhibits nucleolar stress and reduces the sensitivity of hepatocellular carcinoma to oxaliplatin
Genes & Diseases 2025cited by 1position: middledoi
Multi-omics analysis of macrophage-associated receptor and ligand reveals a strong prognostic signature and subtypes in hepatocellular carcinoma
Scientific Reports 2024cited by 4position: middledoi
A clinical prediction model for distant metastases of pediatric neuroblastoma: an analysis based on the SEER database
Frontiers in Pediatrics 2024cited by 3position: middledoi
Xuefu Zhuyu Decoction Alleviates Deep Vein Thrombosis Through Inhibiting the Activation of Platelet and Neutrophil Via Sirt1/Nf-Κb Pathway
SSRN Electronic Journal 2024cited by 0position: middledoi
Supercritical antisolvent-fluidized bed for the preparation of dry powder inhaler for pulmonary delivery of nanomedicine
International Journal of Pharmaceutics 2023cited by 16position: middledoi
Supercritical fluid coating of flavonoids on excipients enhances drug release and antioxidant activity
International Journal of Pharmaceutics 2023cited by 6position: middledoi
Characterization of excipients to improve pharmaceutical properties of sirolimus in the supercritical anti-solvent fluidized process
International Journal of Pharmaceutics 2021cited by 9position: middledoi
Overexpression of PCBP2 contributes to poor prognosis and enhanced cell growth in human hepatocellular carcinoma
Oncology Reports 2016cited by 71position: firstdoi
Downregulated DYRK2 expression is associated with poor prognosis and Oxaliplatin resistance in hepatocellular carcinoma
Pathology - Research and Practice 2016cited by 35position: firstdoi
Silencing of CtBP1 suppresses the migration in human glioma cells
Journal of Molecular Histology 2016cited by 14position: lastdoi
The role of Alix in the proliferation of human glioma cells
Human Pathology 2016cited by 7position: middledoi
Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma
Digestive Diseases and Sciences 2015cited by 32position: middledoi
Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma
Digestive Diseases and Sciences 2015cited by 31position: middledoi
Overexpression of SYF2 correlates with enhanced cell growth and poor prognosis in human hepatocellular carcinoma
Molecular and Cellular Biochemistry 2015cited by 25position: lastdoi
The DNA damage repair protein Ku70 regulates tumor cell and hepatic carcinogenesis by interacting with FOXO4
Pathology - Research and Practice 2015cited by 21position: middledoi
Knockdown of PFTK1 Inhibits the Migration of Glioma Cells
Journal of Molecular Neuroscience 2015cited by 15position: middledoi
The RNA-binding protein Sam68 regulates tumor cell viability and hepatic carcinogenesis by inhibiting the transcriptional activity of FOXOs
Journal of Molecular Histology 2015cited by 14position: lastdoi
HES5 promotes cell proliferation and invasion through activation of STAT3 and predicts poor survival in hepatocellular carcinoma
Experimental and Molecular Pathology 2015cited by 14position: middledoi
Expression and clinical role of RBQ3 in gliomas
Journal of the Neurological Sciences 2015cited by 10position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jian Xu · Zhejiang International Studies University8 papers (2015–2024)Weidong Shi · Jiangsu University7 papers (2015–2016)Hui Fan · Fudan University5 papers (2015–2015)Runzhou Ni · Nantong University5 papers (2015–2015)Chengjin Zhao · Nantong University4 papers (2015–2016)Zhenwen Qiu · Guangzhou University of Chinese Medicine3 papers (2021–2023)Na Ban · Nantong University3 papers (2015–2016)Zhen Bao · Soochow University3 papers (2015–2016)Tao Tao · Shenzhen Luohu People's Hospital3 papers (2015–2016)Qingguo Li · Guangzhou University of Chinese Medicine3 papers (2021–2023)Zhiwei Xu · Nantong University3 papers (2015–2016)Shusen Zhang · Hebei Medical University3 papers (2015–2015)Wenkai Ni · Fudan University3 papers (2015–2016)Shirong Dai · Nantong University3 papers (2015–2016)Buyou Chen · Nantong University3 papers (2015–2016)Jianbing Ren · Nantong University3 papers (2015–2016)Jie Sun · University of Illinois Urbana-Champaign3 papers (2015–2016)Fangle Liu · Guangzhou University of Chinese Medicine2 papers (2024–2025)Zicheng Zhong · Guangzhou University of Chinese Medicine2 papers (2023–2023)Hongling He · Guangzhou University of Chinese Medicine2 papers (2021–2023)